drugset / Trial / NCT00864357

A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions

NCT00864357

Phase 1 Completed 40 enrolled Actavis Inc.
RandomizedCrossoverOpen-label

Summary

To compare the relative bioavailability of oxycodone HCl 5 mg / ibuprofen 400 mg tablets (Actavis Elizabeth LLC, Lot No. PI-1565) with that of COMBONOX® tablets (Forest Pharmaceuticals, Inc., Lot No. 010550) in healthy adult volunteers under non-fasting conditions.

Timeline

Start
2006-10
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg
Subject Oxycodone Other / unclassified 5 mg

Indications

No indication recorded.